Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.

about

Prostaglandin I2 Suppresses Proinflammatory Chemokine Expression, CD4 T Cell Activation, and STAT6-Independent Allergic Lung Inflammation Iloprost Affects Macrophage Activation and CCL2 Concentrations in a Microdialysis Model in Rats.

P2860

Q41483184-25527D69-0CC5-4001-A15B-18ABA1CB6FFF Q47228393-81EE2D58-CBF3-42A3-8ADD-0457BDBF4FF2

P2860

Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.

Item

http://www.wikidata.org/entity/Q38963041

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Effect of prostaglandin I2 ana ...... human monocyte and macrophage.

@en

type

Item

label

Effect of prostaglandin I2 ana ...... human monocyte and macrophage.

@en

prefLabel

Effect of prostaglandin I2 ana ...... human monocyte and macrophage.

@en

P1476

Effect of prostaglandin I2 ana ...... human monocyte and macrophage.

@en

P2093

Chang-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

Chih-Hsing Hung

http://www.w3.org/2001/XMLSchema#string

Chong-Chao Hsieh

http://www.w3.org/2001/XMLSchema#string

Hsuan-Fu Kuo

http://www.w3.org/2001/XMLSchema#string

Min-Sheng Lee

http://www.w3.org/2001/XMLSchema#string

Ming-Kai Tsai

http://www.w3.org/2001/XMLSchema#string

Ming-Yii Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokines--chemotactic cytokines that mediate inflammation

Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels

The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages.

Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.

The pathophysiology of acute coronary syndromes

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Prostaglandin synthases: recent developments and a novel hypothesis.

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.

Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.

Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.

P2888

s10238-014-0304-7

P304

245-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10238-014-0304-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013268122

http://www.w3.org/2001/XMLSchema#string

P698

25154882

http://www.w3.org/2001/XMLSchema#string

Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.

about

P2860

P2860

Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698